“To fully realize its strategic plan and meet the needs of its growing patient volume, Genome Medical is realigning its company priorities and streamlining company operations to focus on its core operations for genetic services,” a company spokesperson wrote in a statement to Becker’s.
Company founder and CEO Lisa Alderson is stepping down and moving into a strategic advisory role. She will be replaced by Jill Davies, the co-founder and CEO of GeneMatters, which was acquired by Genome Medical in 2021.
“I am proud of Genome Medical’s accomplishments over the last six years,” Ms. Alderson said in the statement. “Genome Medical is transforming healthcare and enabling equitable access to precision medicine for all through our partnerships with health systems, payers, diagnostic testing labs, and biopharma companies.”
The move follows downsizings at other genomics companies amid broader shifts in the health tech industry.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
